Aspirin Therapy on Prophylactic Anticoagulation for Patients Hospitalized With COVID‐19: A Propensity Score‐Matched Cohort Analysis of the HOPE‐COVID‐19 Registry

BACKGROUND: COVID‐19 is an infectious illness, featured by an increased risk of thromboembolism. However, no standard antithrombotic therapy is currently recommended for patients hospitalized with COVID‐19. The aim of this study was to evaluate safety and efficacy of additional therapy with aspirin...

Descripción completa

Detalles Bibliográficos
Autores principales: Santoro, Francesco, Núñez‐Gil, Ivan J., Vitale, Enrica, Viana‐Llamas, María C., Romero, Rodolfo, Maroun Eid, Charbel, Feltes Guzman, Gisela, Becerra‐Muñoz, Victor Manuel, Fernández Rozas, Inmaculada, Uribarri, Aitor, Alfonso‐Rodriguez, Emilio, García Aguado, Marcos, Huang, Jia, Castro Mejía, Alex Fernando, Garcia Prieto, Juan Fortunato, Elola, Javier, Ugo, Fabrizio, Cerrato, Enrico, Signes‐Costa, Jaime, Raposeiras Roubin, Sergio, Jativa Mendez, Jorge Luis, Espejo Paeres, Carolina, López Masjuan, Alvaro, Marin, Francisco, Guerra, Federico, El‐Battrawy, Ibrahim, Cortese, Bernardo, Ramakrishna, Harish, Perez‐Villacastín, Julian, Fernandez‐Ortiz, Antonio, Brunetti, Natale Daniele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9333361/
https://www.ncbi.nlm.nih.gov/pubmed/35730631
http://dx.doi.org/10.1161/JAHA.121.024530

Ejemplares similares

Ejemplares similares